Cook MyoSite is leading the pursuit of muscle-derived cell therapies to solve unmet needs in mainstream indications
Cook MyoSite, Inc., a subsidiary of the Cook Group, was established in 2002 to pioneer advancements in cellular technologies. Driven by a belief in the human body's restorative abilities, Cook MyoSite leverages extensive expertise in muscle-derived cell technology for therapeutic applications.
Our commitment to innovation, quality, and scientific exploration has propelled the development and delivery of autologous muscle-derived cell (AMDC) technologies, now under investigation in leading clinical trials for various medical uses. We partner with researchers and companies across the globe, offering insights, products, and services to support research in human muscle cell applications. For more than 20 years, our team has been dedicated to overcoming scientific boundaries, championing the body's healing capabilities, and enabling individuals to harness their own muscles for recovery.